Assoc. Prof. Cihangir Yandım
Faculty of Engineering
Genetics and Bioengineering
Coordinator, Izmir University of Economics
Coordinator, Izmir University of Economis
Assoc. Prof. Cihangir Yandım
Faculty of Engineering
Genetics and Bioengineering
Coordinator, Izmir University of Economics
Coordinator, Izmir University of Economis
PROJECTS
Participant in projects supported by international organizations
- Investigating cholinergic activation in osteoarthritis and revealing new drug candiates
(2024-2025) The Scientific and Technological Research Council of Turkey (EU COST action)
- Non-catalytic functions of AKT in cancer
(2014-2015) Cancer Research UK
- Friedreich's Ataxia and HDAC inhibition therapy
(2012-2013) Ataxia UK
- Genomic regulation of sexual dimorphism
(2009-2010) Medical Research Council of United Kingdom
- Investigations into the effects of vitamin D on macrophage development
(2006-2007) Harvard Medical School
- Pax7 gene and its effects on muscle stem cell development
(2005-2006) University of Texas Southwestern Medical Center
- Gene regulation in Friedreich's Ataxia
(2008-2009) Medical Research Council of United Kingdom
Manager or Director in projects supported by national organizations such as TUBITAK, DPT
- Revealing GPR adhesion protein function in pancreatic adenocarcinoma and understanding its potential for treatment
(2024-2025) The Scientific and Technological Research Council of Turkey (EU COST action)
- Genomic evolution of epithelial cell senescence
(2023-2024) The Scientific and Technological Research Council of Turkey (TUBITAK)
- Investigating synthetic lethality in liver cancer based on DNA repeair mechanisms
(2021-2022) Izmir University of Economics
- Mapping the genomic evolution of cellular senescence
(2021-2022) The Scientific and Technological Research Council of Turkey (TUBITAK)
- Characterisation of satellite DNA expression in hepatocarcinogenesis
(2019-2020) The Scientific and Technological Research Council of Turkey (TUBITAK)
Participant in projects supported by national organizations such as TUBITAK, DPT
- Targeting telomeric DNA damage in liver cancer
(2021-2022) The Scientific and Technological Research Council of Turkey (TUBITAK)
- Repeat expression dynamics of the developing human embryo
(2018-2019) Izmir Biomedicine and Genome Center